EANM The European Association of Nuclear Medicine (EANM) is the largest non-profit medical organisation dedicated to nuclear medicine in Europe.

The EANM is the largest non-profit medical organisation dedicated to nuclear medicine in Europe. Since its establishment in 1985, the EANM has consistently aimed to provide an interactive platform for the sharing and discussion of cutting-edge developments in the field, fostering the exchange of knowledge on disease diagnosis and treatment. Nuclear medicine is a multi-professional, independent, medical discipline based on the application of probes labelled with radionuclides (radiopharmaceuticals) to both diagnose and treat various diseases, such as cancer. Its scope encompasses molecular imaging, image-guided procedures, and targeted radionuclide therapy. Nuclear medicine procedures target specific physio-pathological processes or features underlying a disease directly at the molecular level. Employing sophisticated hybrid technology and a multimodal approach, nuclear medicine ensures a comprehensive diagnostic map, fostering precision medicine to diagnose, prognosticate, administer targeted therapy, guide treatment, and monitor its effects on patients. As a leading organisation in the field, the EANM brings together professionals from different backgrounds, including nuclear medicine physicians, medical physicists, radiochemists, pharmacists, technologists and other experts working in nuclear medicine or related fields. The EANM also works closely with 40 European nuclear medicine national societies, 20 non-European affiliated societies, EU institutions, international bodies and other medical societies to bring nuclear medicine to the forefront. Globally recognised for its Annual Congress, which attracts more than 7,000 attendees each year, the EANM is also the driving force behind the European School of Multimodality Imaging & Therapy (ESMIT). ESMIT offers a broad spectrum of educational programmes designed to enhance expertise in the field.

✅ 𝗪𝗲 𝗮𝗿𝗲 𝗵𝗮𝗽𝗽𝘆 𝘁𝗼 𝗵𝗮𝘃𝗲 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹𝗹𝘆 𝗰𝗼𝗻𝗰𝗹𝘂𝗱𝗲𝗱 𝗼𝘂𝗿 𝗰𝗼𝘂𝗿𝘀𝗲 “𝗙𝗼𝗰𝘂𝘀 𝗼𝗻 𝗙𝗗𝗚 𝗣𝗘𝗧/𝗖𝗧 𝗶𝗻 𝗜𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗼𝗿𝘆 𝗮𝗻𝗱 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝘂𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲𝘀”!T...
21/11/2025

✅ 𝗪𝗲 𝗮𝗿𝗲 𝗵𝗮𝗽𝗽𝘆 𝘁𝗼 𝗵𝗮𝘃𝗲 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹𝗹𝘆 𝗰𝗼𝗻𝗰𝗹𝘂𝗱𝗲𝗱 𝗼𝘂𝗿 𝗰𝗼𝘂𝗿𝘀𝗲 “𝗙𝗼𝗰𝘂𝘀 𝗼𝗻 𝗙𝗗𝗚 𝗣𝗘𝗧/𝗖𝗧 𝗶𝗻 𝗜𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗼𝗿𝘆 𝗮𝗻𝗱 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝘂𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲𝘀”!

This one and a half day onsite course in Vienna provided the participants with an 𝗼𝘃𝗲𝗿𝘃𝗶𝗲𝘄 𝗼𝗳 𝘁𝗵𝗲 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝗮𝗻𝗱 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗮𝗹 𝘂𝘀𝗲 𝗼𝗳 [𝟭𝟴𝗙]𝗙𝗗𝗚-𝗣𝗘𝗧/𝗖𝗧 𝗶𝗻 𝘀𝘂𝘀𝗽𝗲𝗰𝘁𝗲𝗱 𝗶𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻 and covered the most well-established indications. The sessions mixed short overview lectures with interactive sessions in order to allow participants to engage in discussions and exchange experiences on daily practices with each other and the faculty.

🎓 𝗔 𝗯𝗶𝗴 𝘁𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 𝘁𝗼 𝗼𝘂𝗿 𝗲𝘅𝗽𝗲𝗿𝘁 𝘀𝗽𝗲𝗮𝗸𝗲𝗿𝘀 Søren Hess, Olivier Gheysens, Ayah Nawwar, and Giorgio Treglia for leading the sessions, sharing their experience and fostering engaging case discussions!

🙌 𝗔𝗻𝗱 𝘁𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 𝘁𝗼 𝗮𝗹𝗹 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝗻𝘁𝘀 for joining us in Vienna, as well as for your dedication and active engagement. We hope the course supports your future clinical practice!

📣 We’d love to hear your reflections and key takeaways - feel free to share your course experience, insights, or favourite moments on LinkedIn using !

Don’t forget! ⏰ The abstract and case submission deadline for the International Conference on Nuclear Cardiology (ICNC20...
21/11/2025

Don’t forget! ⏰

The abstract and case submission deadline for the International Conference on Nuclear Cardiology (ICNC2026) is approaching.

📅 May 17-19, 2026
📍 Berlin, Germany
🤝 Co-organised by EANM and the American Society of Nuclear Cardiology

Submit your abstract before November 25 👉 https://icnc.community/registration/

💡 Have your say in nuclear medicine clinical trials! We’re inviting clinical research professionals to complete a short ...
21/11/2025

💡 Have your say in nuclear medicine clinical trials!

We’re inviting clinical research professionals to complete a short 10-minute survey on the challenges and opportunities faced by academic and non-commercial sponsors.
🔗 https://app.sli.do/event/3Dnipp7d9KykvefV4gXY7R

🇪🇺 Your input will help EANM shape ACT EU (Accelerating Clinical Trials in the EU) and contribute to efforts to modernise and streamline clinical research across Europe.

⏰ The survey is open until 31 December. Please take a few minutes to share your experience and feel free to pass it on to colleagues!

19/11/2025

EANM in the news! 🗞️

Tatjana Traub-Weidinger, member of the EANM Neuroimaging Committee, was recently featured in the Gesundheitsmagazin of the Austrian newspaper Die Presse.

In the article, she highlights the essential role of in patient care. This is another important step in ’s mission to increase the visibility of nuclear medicine across Europe!

If you speak German, don’t miss this insightful read 👉https://eanm.org/wp-content/uploads/2025/11/Gesundheitsmagazin_15-11-2025_50.pdf

🧠     – 𝗧𝗿𝗮𝗰𝗸 𝟭 𝗣𝗿𝗲𝘃𝗶𝗲𝘄𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗼𝗳 𝗔𝗺𝘆𝗹𝗼𝗶𝗱 & 𝗧𝗮𝘂 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆: 𝗖𝗼𝗺𝗯𝗶𝗻𝗶𝗻𝗴 𝗜𝗺𝗮𝗴𝗶𝗻𝗴 & 𝗙𝗹𝘂𝗶𝗱 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀Join leading experts as...
19/11/2025

🧠 – 𝗧𝗿𝗮𝗰𝗸 𝟭 𝗣𝗿𝗲𝘃𝗶𝗲𝘄

𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗼𝗳 𝗔𝗺𝘆𝗹𝗼𝗶𝗱 & 𝗧𝗮𝘂 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆: 𝗖𝗼𝗺𝗯𝗶𝗻𝗶𝗻𝗴 𝗜𝗺𝗮𝗴𝗶𝗻𝗴 & 𝗙𝗹𝘂𝗶𝗱 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀

Join leading experts as they explore how , , and can be used together to improve ’s disease diagnosis. The session features insights from Charlotte Teunissen, Shorena Janelidze, Pedro Rosa Neto, and a lively debate with Valentina Garibotto, Alexander Drzezga, and Sebastiaan Engelborghs on whether plasma markers alone are enough.

🗓️ Dates: February 5-7, 2026
📍 Location: Palma de Mallorca, Spain
📃 Scientific Programme: https://bit.ly/3m5gaIQ
➡️ Register Now: https://bit.ly/3Na1DZ7

Every week, nuclear medicine helps diagnose and treat countless conditions across Europe. But when radiopharmaceuticals ...
12/11/2025

Every week, nuclear medicine helps diagnose and treat countless conditions across Europe. But when radiopharmaceuticals run short, patients suffer. Their care is delayed. Their hope put on hold.

We’re proud to be part of the European Medicines Agency's campaign, working with colleagues across Europe to keep essential medicines available for everyone who needs them.

Watch and share a video with our president, Paola Anna Erba, on what happens when supply chains fail and why securing radiopharmaceutical access is vital for patients and for Europe’s healthcare future.

Because this isn’t just about supply chains. It’s about people.

📽️ Watch now on Youtube:

Fighting medicine shortages takes a team. Nuclear medicine relies on radiopharmaceuticals to diagnose and treat serious diseases like cancer, cardiovascular,...

📢 Join the upcoming live webinar "𝗣𝗮𝗲𝗱𝗶𝗮𝘁𝗿𝗶𝗰 𝗧𝗵𝘆𝗿𝗼𝗶𝗱 𝗖𝗮𝗻𝗰𝗲𝗿" taking place this Friday!📅 𝗗𝗮𝘁𝗲: November 14, 2025🕐 𝗧𝗶𝗺𝗲: 1...
11/11/2025

📢 Join the upcoming live webinar "𝗣𝗮𝗲𝗱𝗶𝗮𝘁𝗿𝗶𝗰 𝗧𝗵𝘆𝗿𝗼𝗶𝗱 𝗖𝗮𝗻𝗰𝗲𝗿" taking place this Friday!

📅 𝗗𝗮𝘁𝗲: November 14, 2025
🕐 𝗧𝗶𝗺𝗲: 13:30 CET
🎟️ 𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻: FREE
🔗 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗵𝗲𝗿𝗲: https://elearning.eanm.org/course/live-webinar-paediatric-thyroid-cancer-november-14-2025

💡 The ESMIT live webinar “𝗣𝗮𝗲𝗱𝗶𝗮𝘁𝗿𝗶𝗰 𝗧𝗵𝘆𝗿𝗼𝗶𝗱 𝗖𝗮𝗻𝗰𝗲𝗿” aims to underlie the most relevant differences with the adults DCT regarding epidemiology, genetics, pathology, immunoistopathology, diagnostic tools and treatment, especially for RAI theranostic procedure. Additionally, the webinar will also go over the main GL recommendations and present and discuss two emblematic or tricky cases.

𝗟𝗲𝗮𝗿𝗻𝗶𝗻𝗴 𝗢𝗯𝗷𝗲𝗰𝘁𝗶𝘃𝗲𝘀:
✅ The aim of this course is to sensitise the attendees about the correct way to recognise, diagnose and treat DTC in children.

𝗧𝗮𝗿𝗴𝗲𝘁 𝗔𝘂𝗱𝗶𝗲𝗻𝗰𝗲:
Physicians, residents with a special interest in endocrinology and endo-oncology, nuclear medicine specialists, nurses and technicians from nuclear medicine units

🎙️ 𝗠𝗼𝗱𝗲𝗿𝗮𝘁𝗼𝗿:
Catia Olianti

👥 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀:
Desiree Deandreis
Livia Lamartina

Don’t miss out on this chance to !
Now also on the go with the 𝗘𝗦𝗠𝗜𝗧 𝗤𝘂𝗶𝘇𝗨𝗽 𝗔𝗽𝗽!

🔗 Get the new 𝗘𝗦𝗠𝗜𝗧 𝗤𝘂𝗶𝘇𝗨𝗽 𝗔𝗽𝗽 here: https://esmit.eanm.org/esmit-quizup-app/

New monthly series! 🆕  Starting this month, we will regularly showcase the latest EANM publications. A big thank-you to ...
11/11/2025

New monthly series! 🆕

Starting this month, we will regularly showcase the latest EANM publications. A big thank-you to all authors, reviewers, and partner societies for their commitment to advancing our field!

Browse the list below, and find direct links in the comments 👇

➡️ In The EANM Journal:

🔹 Why not a new journal?
🔹 A glass to the past, a toast to the future: forty years of EANM
🔹 Perspectives of the EANM on early perfusion imaging in the context of amyloid PET imaging protocols
🔹 EANM insights on PET-based response assessment in neuro-oncology: things are moving forward!
🔹 A roadmap for AI-aided digital twins in computational nuclear oncology: a position paper by the EANM
🔹 EANM Focus Meeting 6 consensus on molecular imaging in breast cancer (endorsed by European Society of Breast Imaging (EUSOBI), European Society of Surgical Oncology (ESSO), European Society for Radiotherapy and Oncology (ESTRO), EUROPA DONNA - The European Breast Cancer Coalition)
🔹 [18F]FDG PET/CT: EANM procedure guidelines for tumour imaging: version 3.0.

➡️ In EANM Innovation:

🔹 Welcome to EANM Innovation – A new journey begins
🔹 Joint EANM/Society of Nuclear Medicine and Molecular Imaging (SNMMI) procedural guideline for paediatric bone hybrid imaging with 99mTc-labelled radiopharmaceuticals and [18F]fluoride
🔹 Bone SPECT/CT in suspected facet joint arthropathy and non-infectious postoperative spine conditions. Part 1: Systematic review and evidence map
🔹 Bone SPECT/CT in suspected facet joint arthropathy and non-infectious postoperative spine conditions. Part 2: Joint EANM/European Society of Neuroradiology/EUROSPINE, the Spine Society of Europe clinical practice consensus guideline

➡️ In other journals:

🔹 SNMMI/EANM/American Society of Nuclear Cardiology/AMERICAN COLLEGE OF NUCLEAR MEDICINE INC Procedure Standard/Practice Guideline for 18F-Flurpiridaz PET Myocardial Perfusion Imaging and Blood Flow Quantitation I The Journal of Nuclear Medicine - JNM (2025)
🔹 The SNMMI Procedure Standard/EANM Practice Guideline for Radionuclide Brain Perfusion Scintigraphy in Suspected Death by Neurologic Criteria (Brain Death) 3.0. I Journal of Nuclear Medicine Technology (2025)
🔹 SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization I JNM (2025)

➡️ Endorsed

🔹 White paper on the current state of imaging biomarkers in paediatric oncology I Pediatric Radiology (2025)

📢 Join our next live webinar "𝗡𝘂𝗰𝗹𝗲𝗮𝗿 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲-𝗿𝗲𝗹𝗮𝘁𝗲𝗱 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗘𝗦𝗠𝗢 𝟮𝟬𝟮𝟱" taking place this Friday!📅 𝗗𝗮𝘁𝗲: Novem...
04/11/2025

📢 Join our next live webinar "𝗡𝘂𝗰𝗹𝗲𝗮𝗿 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲-𝗿𝗲𝗹𝗮𝘁𝗲𝗱 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗘𝗦𝗠𝗢 𝟮𝟬𝟮𝟱" taking place this Friday!

📅 𝗗𝗮𝘁𝗲: November 7, 2025
🕐 𝗧𝗶𝗺𝗲: 13:30 CET
🎟️ 𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻: FREE
🔗 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗵𝗲𝗿𝗲: https://elearning.eanm.org/course/live-webinar-nuclear-medicine-related-highlights-from-esmo-2025-november-7-2025

💡 This ESMO 2025 webinar will cover a range of topics, including the latest advancements treatment options, imaging modalities and performant tracers related to solid and liquid tumours. The focus of this event will be the recent advances in solid & liquid tumour treatment, clinical trials and emerging therapies, biomarkers in solid tumours and multidisciplinary approaches. The importance of collaboration among medical oncologists, radiologists, nuclear medicine physicians, pathologists and surgeons will be underlined, based on clinical examples. Furthermore, challenges and opportunities in immunotherapy for solid tumours will be addressed, with special attention for personalised treatment plans in specific cancers, like lung cancer, breast cancer, colorectal, and prostate cancer.

𝗟𝗲𝗮𝗿𝗻𝗶𝗻𝗴 𝗢𝗯𝗷𝗲𝗰𝘁𝗶𝘃𝗲𝘀:
✅ Attendees will get insight into recent advances in solid/ liquid tumuor treatment
✅ Attendees will be familiarised with the latest developments when diagnosing, staging and treating different types of solid and liquid tumours


𝗧𝗮𝗿𝗴𝗲𝘁 𝗔𝘂𝗱𝗶𝗲𝗻𝗰𝗲:
Fellows and Medical Specialists in Nuclear Medicine, Radiology, Medical Oncology, Urology, Surgery, Pathology and Radiation Oncology

🎙️ 𝗠𝗼𝗱𝗲𝗿𝗮𝘁𝗼𝗿:
David Kersting

👥 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀:
Karolien Goffin
Matthias Eiber

Don’t miss out on this chance to !
Now also on the go with the 𝗘𝗦𝗠𝗜𝗧 𝗤𝘂𝗶𝘇𝗨𝗽 𝗔𝗽𝗽!

🔗 Get the new 𝗘𝗦𝗠𝗜𝗧 𝗤𝘂𝗶𝘇𝗨𝗽 𝗔𝗽𝗽 here: https://lnkd.in/d3BjHuAm

Missed the   episodes during  ? No worries — you can watch them anytime! 📺 This year’s programme featured insightful int...
04/11/2025

Missed the episodes during ? No worries — you can watch them anytime! 📺

This year’s programme featured insightful interviews on key topics, including:

🔹 EANM's involvement in EU affairs & projects
🔹 EANM Journals
🔹 Life as an EANM volunteer
🔹 EARL Theranostics Centers of Excellence certification Level 2
🔹 ICNC 2026 & updates in nuclear cardiology
🔹 RLT Angels
🔹 EANM Focus Meeting 7 on Alzheimer’s disease
🔹 EANM 40th anniversary

Make sure to reshare our TV episodes with your network! 🔄

👉 Watch now: https://youtube.com/playlist?list=PLuCRB1E3sSyTJnfMlo27gd-9FpxQM3hly&si=zBGW3LOonLNWQ3yf

Reminder 🚨The 2025 EANM Technologists’ Guide 'Women’s Health: The Role of Nuclear Medicine' is available for free on our...
31/10/2025

Reminder 🚨

The 2025 EANM Technologists’ Guide 'Women’s Health: The Role of Nuclear Medicine' is available for free on our website!

Don’t miss the chance to explore this valuable resource 👉https://eanm.org/wp-content/uploads/2025/07/EANM_2025_Tech_Guide_Women_Health.pdf

EANM Technologists Committee

Adresse

Schmalzhofgasse 26
Vienna
1060

Öffnungszeiten

Montag 09:00 - 17:00
Dienstag 09:00 - 17:00
Mittwoch 09:00 - 17:00
Donnerstag 09:00 - 17:00
Freitag 09:00 - 17:00

Telefon

+4318904427

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von EANM erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram